Nouscom Announces Clinical Trial Collaboration and Supply Ag

BASEL, Switzerland, Jan. 5, 2023 /PRNewswire/ -- Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, today announced that it has entered

Related Keywords

United States , Ankara , Turkey , Switzerland , Eleanor Perkin , Prnewswire Nouscom , Marwang Fakih , Richard Davis , Sylvie Berrebi , Bristol Myers Squibb , Marina Udier , Merck Co Inc , Linkedin , Merck Sharp Dohme , Janssen Research Development , Microsatellite Instable High , Metastatic Colorectal Cancer , Chief Executive Officer , Merck Sharp , Professor Marwan , Based Vaccine Promotes Neoantigen Specific , Science Translational Medicine , Great Ape Adenoviral , Modified Vaccinia Ankara , Lynch Syndrome Carriers , Myeloproliferative Neoplasms , Janssen Research , Nouscom , Nnounces , Linical , Trial , Collaboration , Supply , Agreement , Valuate , Yous , Combination , Keytruda , Pembrolizumab , Hase , Randomized , Trials , Mmr , Thigh , Metastatic , Olorectal , Dancer ,